Organization: University Health Network

The Short Report – August 3, 2022: CAMH awarded the first federal psilocybin study grant; C6 Launch Systems prepares for suborbital test at a foreign spaceport; Ottawa launches calls for Women Entrepreneurship Strategy Ecosystem Fund projects, and more.

CAMH receives first CIHR grant to study psilocybin and its effect on treatment-resistant depression; Toronto-based C6 Launch Systems prepares for its first suborbital test at a foreign spaceport through its Brazilian subsidiary, Ottawa makes $40 million available for projects that deliver business supports for women entrepreneurs, and more.

Canada showed strong growth in patents for pandemic prevention technology in last two decades, CIPO report finds

Canada ranked eighth globally in the number of patented pandemic mitigation technologies filed by institutions worldwide between 1999 and 2018, according to a report by the Canadian Intellectual Property Office done in collaboration with the National Research Council. The report found that Canadian institutions had a high relative specialization for pandemic mitigation technologies, especially in the therapeutics and vaccine development research area.

Opinion Leader: Continued government support is critical to maintain Ontario’s global competitiveness in regenerative medicine

Ongoing provincial government support for the Ontario Institute for Regenerative Medicine (OIRM) is critical to maintain Ontario’s global competitiveness in the fast-growing field of regenerative medicine which is developing cutting-edge products and therapies resulting from stem cell research, Dr. Duncan Stewart, president and scientific director of OIRM, and Dr. Tim Smith, chair of the board of directors at OIRM, say in an op-ed.